<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04180000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P17787</UniProt_ID>
  <Seq_Length>502</Seq_Length>
  <Molecule_Weight>57019</Molecule_Weight>
  <KEGG_ID>hsa:1141</KEGG_ID>
  <Orthology_ID>K04813</Orthology_ID>
  <Function_Summary>After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.</Function_Summary>
  <Pfam_ID>PF02931:Neur_chan_LBD@@PF02932:Neur_chan_memb</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Protein which forms or is a component of a ligand-gated channel. Ligand-gated channels are transmembrane ion channels whose permeability is increased by the binding of a specific ligand, such as neurotransmitters, ionositol triphosphates, and cyclic nucleotides.</Detail>
      <Keyword>Ligand-gated ion channel</Keyword>
      <Ontology_ID>KW-1071</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transmembrane transfer of a cation by a channel that acts as a nicotinic acetylcholine receptor, and opens upon binding acetylcholine.</Detail>
      <Keyword>Nicotinic acetylcholine-activated cation-selective channel activity</Keyword>
      <Ontology_ID>GO:0004889</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with acetylcholine, an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions.</Detail>
      <Keyword>Acetylcholine binding</Keyword>
      <Ontology_ID>GO:0042166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.</Detail>
      <Keyword>Ion channel activity</Keyword>
      <Ontology_ID>GO:0005216</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with acetylcholine to initiate a change in cell activity.</Detail>
      <Keyword>Acetylcholine receptor activity</Keyword>
      <Ontology_ID>GO:0015464</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>287</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>397</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of dopamine.</Detail>
      <Keyword>Positive regulation of dopamine secretion</Keyword>
      <Ontology_ID>GO:0033603</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.</Detail>
      <Keyword>Response to ethanol</Keyword>
      <Ontology_ID>GO:0045471</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.</Detail>
      <Keyword>Locomotory behavior</Keyword>
      <Ontology_ID>GO:0007626</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. For example, the initial depolarization during the rising phase of an action potential is in the direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.</Detail>
      <Keyword>Membrane depolarization</Keyword>
      <Ontology_ID>GO:0051899</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of B cell proliferation.</Detail>
      <Keyword>Positive regulation of B cell proliferation</Keyword>
      <Ontology_ID>GO:0030890</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of action potential creation, propagation or termination. An action potential is a spike of membrane depolarization and repolarization that travels along the membrane of a cell.</Detail>
      <Keyword>Negative regulation of action potential</Keyword>
      <Ontology_ID>GO:0045759</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to another neuron across a synapse using the neurotransmitter acetylcholine.</Detail>
      <Keyword>Synaptic transmission, cholinergic</Keyword>
      <Ontology_ID>GO:0007271</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Behavior that occurs predominantly, or only, in individuals that are part of a group.</Detail>
      <Keyword>Social behavior</Keyword>
      <Ontology_ID>GO:0035176</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to a smooth muscle in the bladder that contributes to the expulsion of urine from the body.</Detail>
      <Keyword>Synaptic transmission involved in micturition</Keyword>
      <Ontology_ID>GO:0060084</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in the behavior of an organism as a result of a nicotine stimulus.</Detail>
      <Keyword>Behavioral response to nicotine</Keyword>
      <Ontology_ID>GO:0035095</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of the lateral geniculate nucleus over time from its initial formation until its mature state. The lateral geniculate nucleus is the primary processor of visual information received from the retina.</Detail>
      <Keyword>Lateral geniculate nucleus development</Keyword>
      <Ontology_ID>GO:0021771</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of synaptogenesis, the formation of a synapse.</Detail>
      <Keyword>Regulation of synaptogenesis</Keyword>
      <Ontology_ID>GO:0051963</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.</Detail>
      <Keyword>Sensory perception of sound</Keyword>
      <Ontology_ID>GO:0007605</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.</Detail>
      <Keyword>Response to hypoxia</Keyword>
      <Ontology_ID>GO:0001666</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Calcium ion transport</Keyword>
      <Ontology_ID>GO:0006816</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of rapid eye movement (REM) sleep.</Detail>
      <Keyword>Regulation of circadian sleep/wake cycle, REM sleep</Keyword>
      <Ontology_ID>GO:0042320</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structure of the optic nerve is generated and organized. The sensory optic nerve originates from the bipolar cells of the retina and conducts visual information to the brainstem. The optic nerve exits the back of the eye in the orbit, enters the optic canal, and enters the central nervous system at the optic chiasm (crossing) where the nerve fibers become the optic tract just prior to entering the hindbrain.</Detail>
      <Keyword>Optic nerve morphogenesis</Keyword>
      <Ontology_ID>GO:0021631</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of dendrite morphogenesis.</Detail>
      <Keyword>Regulation of dendrite morphogenesis</Keyword>
      <Ontology_ID>GO:0048814</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving dopamine.</Detail>
      <Keyword>Regulation of dopamine metabolic process</Keyword>
      <Ontology_ID>GO:0042053</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process.</Detail>
      <Keyword>Sensory perception of pain</Keyword>
      <Ontology_ID>GO:0019233</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the vestibulocochlear nerve over time, from its formation to the mature structure. This sensory nerve innervates the membranous labyrinth of the inner ear. The vestibular branch innervates the vestibular apparatus that senses head position changes relative to gravity. The auditory branch innervates the cochlear duct, which is connected to the three bony ossicles which transduce sound waves into fluid movement in the cochlea.</Detail>
      <Keyword>Vestibulocochlear nerve development</Keyword>
      <Ontology_ID>GO:0021562</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.</Detail>
      <Keyword>Response to cocaine</Keyword>
      <Ontology_ID>GO:0042220</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.</Detail>
      <Keyword>B cell activation</Keyword>
      <Ontology_ID>GO:0042113</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive a visual stimulus, convert it to a molecular signal, and recognize and characterize the signal. Visual stimuli are detected in the form of photons and are processed to form an image.</Detail>
      <Keyword>Visual perception</Keyword>
      <Ontology_ID>GO:0007601</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Generation of a long process of a CNS neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells in a different central nervous system region.</Detail>
      <Keyword>Central nervous system projection neuron axonogenesis</Keyword>
      <Ontology_ID>GO:0021952</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.</Detail>
      <Keyword>Visual learning</Keyword>
      <Ontology_ID>GO:0008542</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length.</Detail>
      <Keyword>Smooth muscle contraction</Keyword>
      <Ontology_ID>GO:0006939</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).</Detail>
      <Keyword>Memory</Keyword>
      <Ontology_ID>GO:0007613</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Ion transport</Keyword>
      <Ontology_ID>GO:0006811</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MARRCGPVALLLGFGLLRLCSGVWGTDTEERLVEHLLDPSRYNKLIRPATNGSELVTVQLMVSLAQLISVHEREQIMTTNVWLTQEWEDYRLTWKPEEFDNMKKVRLPSKHIWLPDVVLYNNADGMYEVSFYSNAVVSYDGSIFWLPPAIYKSACKIEVKHFPFDQQNCTMKFRSWTYDRTEIDLVLKSEVASLDDFTPSGEWDIVALPGRRNENPDDSTYVDITYDFIIRRKPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSLDVPLVGKYLMFTMVLVTFSIVTSVCVLNVHHRSPTTHTMAPWVKVVFLEKLPALLFMQQPRHHCARQRLRLRRRQREREGAGALFFREAPGADSCTCFVNRASVQGLAGAFGAEPAPVAGPGRSGEPCGCGLREAVDGVRFIADHMRSEDDDQSVSEDWKYVAMVIDRLFLWIFVFVCVFGTIGMFLQPLFQNYTTTTFLHSDHSAPSSK</Protein_Seq>
    <DNA_Seq>CTCCTCCCCCTCACCGTCCCAATTGTATTCCCTGGAAGAGCAGCCGGAAAAGCCTCCGCCTGCTCATACCAGGATAGGCAAGAAGCTGGTTTCTCCTCGCAGCCGGCTCCCTGAGGCCCAGGAACCACCGCGGCGGCCGGCACCACCTGGACCCAGCTCCAGGCGGGCGCGGCTTCAGCACCACGGACAGCGCCCCACCCGCGGCCCTCCCCCCGGCGGCGCGCTCCAGCCGGTGTAGGCGAGGCAGCGAGCTATGCCCGCGGCATGGCCCGGCGCTGCGGCCCCGTGGCGCTGCTCCTTGGCTTCGGCCTCCTCCGGCTGTGCTCAGGGGTGTGGGGTACGGATACAGAGGAGCGGCTGGTGGAGCATCTCCTGGATCCTTCCCGCTACAACAAGCTTATCCGCCCAGCCACCAATGGCTCTGAGCTGGTGACAGTACAGCTTATGGTGTCACTGGCCCAGCTCATCAGTGTGCATGAGCGGGAGCAGATCATGACCACCAATGTCTGGCTGACCCAGGAGTGGGAAGATTATCGCCTCACCTGGAAGCCTGAAGAGTTTGACAACATGAAGAAAGTTCGGCTCCCTTCCAAACACATCTGGCTCCCAGATGTGGTCCTGTACAACAATGCTGACGGCATGTACGAGGTGTCCTTCTATTCCAATGCCGTGGTCTCCTATGATGGCAGCATCTTCTGGCTGCCGCCTGCCATCTACAAGAGCGCATGCAAGATTGAAGTAAAGCACTTCCCATTTGACCAGCAGAACTGCACCATGAAGTTCCGTTCGTGGACCTACGACCGCACAGAGATCGACTTGGTGCTGAAGAGTGAGGTGGCCAGCCTGGACGACTTCACACCTAGTGGTGAGTGGGACATCGTGGCGCTGCCGGGCCGGCGCAACGAGAACCCCGACGACTCTACGTACGTGGACATCACGTATGACTTCATCATTCGCCGCAAGCCGCTCTTCTACACCATCAACCTCATCATCCCCTGTGTGCTCATCACCTCGCTAGCCATCCTTGTCTTCTACCTGCCATCCGACTGTGGCGAGAAGATGACGTTGTGCATCTCAGTGCTGCTGGCGCTCACGGTCTTCCTGCTGCTCATCTCCAAGATCGTGCCTCCCACCTCCCTCGACGTGCCGCTCGTCGGCAAGTACCTCATGTTCACCATGGTGCTTGTCACCTTCTCCATCGTCACCAGCGTGTGCGTGCTCAACGTGCACCACCGCTCGCCCACCACGCACACCATGGCGCCCTGGGTGAAGGTCGTCTTCCTGGAGAAGCTGCCCGCGCTGCTCTTCATGCAGCAGCCACGCCATCATTGCGCCCGTCAGCGCCTGCGCCTGCGGCGACGCCAGCGTGAGCGCGAGGGCGCTGGAGCCCTCTTCTTCCGCGAAGCCCCAGGGGCCGACTCCTGCACGTGCTTCGTCAACCGCGCGTCGGTGCAGGGGTTGGCCGGGGCCTTCGGGGCTGAGCCTGCACCAGTGGCGGGCCCCGGGCGCTCAGGGGAGCCGTGTGGCTGTGGCCTCCGGGAGGCGGTGGACGGCGTGCGCTTCATCGCAGACCACATGCGGAGCGAGGACGATGACCAGAGCGTGAGTGAGGACTGGAAGTACGTCGCCATGGTGATCGACCGCCTCTTCCTCTGGATCTTTGTCTTTGTCTGTGTCTTTGGCACCATCGGCATGTTCCTGCAGCCTCTCTTCCAGAACTACACCACCACCACCTTCCTCCACTCAGACCACTCAGCCCCCAGCTCCAAGTGAGGCCCTTCCTCATCTCCATGCTCTTTCACCCTGCCACCCTCTGCTGCACAGTAGTGTTGGGTGGAGGATGGACGAGTGAGCTACCAGGAAGAGGGGCGCTGCCCCCACAGATCCATCCTTTTGCTTCATCTGGAGTCCCTCCTCCCCCACGCCTCCATCCACACACAGCAGCTCCAACCTGGAGGCTGGACCAACTGCTTTGTTTTGGCTGCTCTCCATCTCTTGTACCAGCCCAGGCAATAGTGTTGAGGAGGGGAGCAAGGCTGCTAAGTGGAAGACAGAGATGGCAGAGCCATCCACCCTGAGGAGTGATGGGCAAGGGGCCAGGAAGGGGACAGGATTGTCTGCTGCCTCCAAGTCATGGGAGAAGAGGGGTATAGGACAAGGGGTGGAAGGGCAGGAGCTCACACCGCACCGGGCTGGCCTGACACAATGGTAGCTCTGAAGGGAGGGGAAGAGAGAGGCCTGGGTGTGACCTGACACCTGCCGCTGCTTGAGTGGACAGCAGCTGGACTGGGTGGGCCCCACAGTGGTCAGCGATTCCTGCCAAGTAGGGTTTAGCCGGGCCCCATGGTCACAGACCCCTGGGGGAGGCTTCCAGCTCAGTCCCACAGCCCCTTGCTTCTAAGGGATCCAGAGACCTGCTCCAGATCCTCTTTCCCCACTGAAGAATTCTGCACCCTCTGGACTTCCCTCTTCTTCCTTCCTTTCTCAGGCTCAAGGTGTGGGGGGCAAGGCTGAGTATTAGGGGAGCTTCTGAGTTCTGAATCTTTGGGTGACCTGCTTGGAGTCTCAGGTCCAAATACTTGAAATCTGTGAGAAGTCCAAGTTCATGGGCTTTTGGAACTGGAAGAACTTTGTACAGCCATGGATTCCAACATAAGCCATGTTGCAGATGAAGAAACTGACCCACACGGTGAGACAAGCACAGGTGGGTCTGACTCTTCCTCCCTGCCCTGAGATCCATCTGTCGAGTGCCCTGTTTTTTCCCCACTTTGAACTGACTGGTTACTCTAAGGAAGTGAACTGAGGATGTTAGCTTTAAGCCAACCCAGCCTCTTTGTCCACAGCAGAGCTGAGGTGAACAGCTGGAACCCTGCTACATCCGTGCTGCTCCAGTCTGTTCTGCTCATGGCTCCATCCTTCTGGCTGTCACTCTTCCTCTTCCCCTTCCCAACCAAACCTGAGCAGCTTTGAAGCAGAACTTGGGAAGGACAGGGCTGCTGCTGCCAGCGACACCTCAGAAAGCATAGCCTCGGCTTCCTGCCCCATGTGTCCCTGGAAGCTGTACCCTGACTCTGCTTCCAGAGGCCAGCAGATGGTGGGTTACAGACGGGTCAGCCTGCCAAGTGCACCTGAGGGACCTGACCTGACACAAGCCATTTTGTCCCTAGAGCCCAGCTGGGACTCCTGCTTCTCTAGGCAGGGCAGAGGGAGGAGACACAGCACAGGCACAGAGCATGGGACAGGGACCCCCGAGTCTGGATTCAAGTCCTGGCCCTGCTAGTAACTCATGTGAGCCAGCTTGAGCAAGTCCCTTCATCTTGCTAGAGCTCAGCTTCCTTGCCTATAAAACGTAGGTGGCAATGCCCTCTTCCTGAGGTTGCTGGGAGGATAAGGCAGTGCTTGTGAAAAAGTCTAGCGCTGTACCTGGCACAGAGTAGATGCTTCATGAATGTTGAGTCTGACAGGCAACTGGAGCTGGTGAGAATGGGGTCCCCTGACTGTCATGCCAGCCTCCCTCCCAGGCCCACTCTTCCCCCCTCTTCCCTGAGGAAACCAAGTCTCCCTTATCAGGAAGAGCTGGGGGAGCTGGGAGGAACATTACAGGAACACCAGAGGGAGTCTAGCGGGTGGGCAGGCTTCTCTCTGCAGCCCCCTCAGCAGTTTCATTCCATTCCTGGGCTGAACCCTTGCCCTGGCCCTGCCTCCCTTCTGGGTCAGCACCTCCTGACACAGGTGTGTGCTCAGGGACCCCAGGCTCTAGTCCTGTACTGGCTGTGGAAGCCTATCACTGGGACAGGAAGCCAGTGGCTGCAGGAGACAGGCCTCAGCGCATCTCGTCTGTCAGGATGGGCTCACGGACACCTTTTCTTGGTAGCAGGGAGTGTCTCTGCACTATGGAAACTTTCCCTCTTCTAGAGCGGATTGGGAGTTGCCTGTATTATGCCTGAACCCTCCTTGAACTCATGGTCCTGGGGAAGGCGTCTTGGAACCAGAAACAGCAACAGGAAAGGAGCCTCCCTCTGAAGGGTAGGATGCCGGCCTGAGGCCCTCCCTCTTGGCTCTCCCAGGGCCTGGGCTACCCCGAGGCCCCAGCAGCTGCTGCTGTGGCTGTACTTGCTTTTAATATTTCCCATACATGGCTGTTGTCCAAGTTAAGTCACCAAATGGTGCTAGAGGGGATGGCAGAGAGCAGCTTGTCCAGCTCCTCTCCATGACCCGGTTAACACACGAGTAAACAGGCCTAGAGCTTGTCTGCTGTTTGACCTCTTTTAAGACCCGGCTGTGCTGCATCTACAAAATGAAGATGACAGAGCTAGCCGAGGTCTTCAGCAAGGAAGAAAGGGGTCAGTGTATATGAAAGGGTTACCTGGGCAGTGTCATTCCCTCCATCTCTGTACGCAGCCCTTTGGGAACCATCACAATAAGGAAGAGGTGAGGGCAGAGGTGAAGGATCCACTGCCCAGGCAAGGTGCTACCATGTGGTGGGAGAGTGTGAACCCTCAAGTGCACTGGGAAGCTTTGGGGAACCACAGTCTCTTCCACCCTTGGGTCGTGTGTCGTCCTCTTCTCTTGATGTCAGGGAAGCCCCTATGCCTCCTTCCCGTGGTGGGGCTATCTCTGCAGAGAATCGGGTGCCCAGCTTAATGCTGGGCAAGGACTGGAGGAAGCTCCAGATCTGGAGGTGGCAGAGATACTGGATGGAAACCTGGAGCAAGGGTTTGGGAGGGGAAGTGAGGAAACAGGTTGAGACTATCTCCATCAGAGATGGCAAGGCCACAGGTGATCTGAGAACTATTTTTGTCTGAAAAGAAGGCATGCACAGGCTCTCTGCTTTTGACAGGTGGCGTTGCAGTGGGAGGAAGGCAGCTTCCTGGCGGGGAGATAGAAATACTAGAACAGCTGGTACCAAGTTATTGAAAATTTAAAAGCAAACAAGACACAGCAGCCCCCAGGTGGTGTGTTCTACTGAGGAAGGCTACGGCAGAGGAAGGGCAAGACCGTTTCCCCCAATGGTCTTGAAACGGAAGAGGAAACAGGGAGGGCTCTTTGGATGGTTTGGGGACCTGGGGCTGTTTGTATCCCAGTATTAGCTCCTGTTACTAAGGGTCTGCTCTGCGCCAGGTCCTCAGCATGCGTTGTCTTTATTCCGCGTGACAATCCTATGGGAAGGGGCCTCCACCTACGTAACAGAAATGCGGCTCAGAAAGACCAAGTGACAGCTAGTGAGTAGTGCTGGGCCTGAACCCCAAAGTCCACACTCTTGCTATAGCCGCTGAGGCAGGCAGAAGAGCTCCTTGGGAGGAAAGTAAGGGGCATTCAAAGCCTTCTCTGAATCACTCCCCAAGCCAGAGTAGACCTGGTTCCAGTTGTCCCCCCCTTGTTTCCGGGCAGAGTCAGGCAGGTGTCATACCATCCCTCCCCGCCCAACCAGTGCTGGCCAGACTCCCATTCACCGACCTTGACTAGACAGCGAACAGCCACCTTTTAGTATTCATCCCAACAGGTCCAGGCGGTCAGTGTGATAGCCACGCAGTTCCTAAGGGACTGTAGGTCTAGGAATCATTAGGACACTCACTCAGCCACCCTCGATGCCCCCATCTTCCCCACACTGCCCTTGGCCTCCCCGCTCTGCACGCCTGGAGTATTTGCACTGGTCTAGCCTACTCCAGGTCAGACTCATTAGGAACTCAAGATTCTCGTAAAGAAAGTTGTTTCCAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>External side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0009897</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Postsynaptic membrane</CellLocal>
      <Ontology_ID>GO:0045211</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nicotinic acetylcholine-gated receptor-channel complex</CellLocal>
      <Ontology_ID>GO:0005892</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Synapse</CellLocal>
      <Ontology_ID>GO:0045202</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell junction</CellLocal>
      <Ontology_ID>GO:0030054</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CHRNB2</Gene_Name>
    <Gene_ID>1141</Gene_ID>
    <Genbank_ACCN>NM_000748</Genbank_ACCN>
    <Protein_ACCN>NP_000739</Protein_ACCN>
    <HGNC_ID>1962</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1141</Gene_URL>
    <UCSC_ID>uc001ffg.3</UCSC_ID>
    <EMBL_ID>ENSG00000160716</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Early Onset Absence Epilepsy</Disease_Name>
      <Disease_Detail>Early Onset Absence Epilepsy</Disease_Detail>
      <Disease_DB>ERL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/early_onset_absence_epilepsy?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schizophrenia</Disease_Name>
      <Disease_Detail>Schizophrenia</Disease_Detail>
      <Disease_DB>SCH015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizophrenia?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chrnb2-Related Nocturnal Frontal Lobe Epilepsy, Autosomal Dominant</Disease_Name>
      <Disease_Detail>Chrnb2-Related Nocturnal Frontal Lobe Epilepsy, Autosomal Dominant</Disease_Detail>
      <Disease_DB>CHR328</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chrnb2_related_nocturnal_frontal_lobe_epilepsy_autosomal_dominant?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epilepsy, Nocturnal Frontal Lobe, 1</Disease_Name>
      <Disease_Detail>Epilepsy</Disease_Detail>
      <Disease_DB>EPL073</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epilepsy_nocturnal_frontal_lobe_1?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epilepsy, Nocturnal Frontal Lobe, 3</Disease_Name>
      <Disease_Detail>Epilepsy</Disease_Detail>
      <Disease_DB>EPL072</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epilepsy_nocturnal_frontal_lobe_3?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nicotine Addiction</Disease_Name>
      <Disease_Detail>Nicotine Addiction</Disease_Detail>
      <Disease_DB>NCT012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nicotine_addiction?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nicotine Dependence</Disease_Name>
      <Disease_Detail>Nicotine Dependence</Disease_Detail>
      <Disease_DB>NCT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nicotine_dependence?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Frontal Lobe Epilepsy</Disease_Name>
      <Disease_Detail>Frontal Lobe Epilepsy</Disease_Detail>
      <Disease_DB>FRN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/frontal_lobe_epilepsy?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</Disease_Name>
      <Disease_Detail>Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</Disease_Detail>
      <Disease_DB>ATS011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/autosomal_dominant_nocturnal_frontal_lobe_epilepsy?search=CHRNB2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>NMR structures of the first transmembrane domain of the neuronal acetylcholine receptor beta 2 subunit</PDB_Title>
      <PDB_ID>2K58</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2K58</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the first transmembrane domain of the neuronal acetylcholine receptor beta 2 subunit</PubMed_Title>
      <Author>Bondarenko, V., et al.</Author>
      <Journal>Biophys.J.(2007)92:1616-1622</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17142275?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR structures of TM domain of the n-Acetylcholine receptor b2 subunit</PDB_Title>
      <PDB_ID>2KSR</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KSR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure of the transmembrane domain of the n-acetylcholine receptor beta2 subunit.</PubMed_Title>
      <Author>Bondarenko, V., et al.</Author>
      <Journal>Biochim.Biophys.Acta(2010)1798:1608-1614</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20441771?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR structures of the second transmembrane domain of the neuronal acetylcholine receptor beta 2 subunit</PDB_Title>
      <PDB_ID>2K59</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2K59</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure and dynamics of the second transmembrane domain   of the neuronal acetylcholine receptor beta 2 subunit</PubMed_Title>
      <Author>Yushmanov, V.E., et al.</Author>
      <Journal>Biochemistry(2003)42:13058-13065</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14596621?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05033</Pathway_ID>
      <Pathway_Title>Nicotine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05033</Pathway_ID>
      <Pathway_Title>Nicotine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
  </Network_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>